Insmed Incorporated, a global biopharmaceutical company, announced a collaboration with Google Cloud to transform the drug discovery, development, and commercialization landscape of the life sciences industry through the use of generative AI. This alliance will harness the power of Google Cloud’s cutting-edge AI technology and Insmed’s expertise in serious and rare diseases with a clear goal of reducing the time and increasing the efficiency of developing and delivering new medicines to appropriate patients.
The collaboration focuses on four key aspects of the life sciences industry—drug discovery, drug development, drug commercialization, and enabling functions—and has already identified one to three projects under each area for completion within the next 18 months, with multiple additional programs to follow.
“At the heart of this partnership is our shared vision to leverage the immense potential of generative AI to reduce the time and cost associated with bringing life-changing therapies to patients with serious and rare conditions,” said Shweta Maniar, global director of Life Science Strategy & Solutions, Google Cloud. “Insmed has a clear focus on improving patient outcomes, and we look forward to the potential impact these efforts may have on patients and on the life sciences industry at large.”
Also Read: Atomic AI Adds Bristol Myers Squibb Veteran Dr. Manjunath Ramarao as Chief Scientific Officer
Insmed has built a generative AI search capability using Vertex AI Search trained on its internal documentation, as well as separate functionality that enables indexed access to available, external medical publications.
“This collaboration represents a multi-year commitment to bring about real change to the drug development process,” said Will Lewis, chair and chief executive officer of Insmed. “Reducing the timeline for drug development and enhancing the delivery of drugs to appropriate patients would represent a major breakthrough for the application of AI in the life sciences ecosystem. Google Cloud is the clear partner of choice in this effort and we are thrilled to work together to pursue a future where groundbreaking therapies are developed with unprecedented speed and precision.”
“Insmed is using Google Cloud infrastructure and AI technology to power this transformation leveraging already available AI modules,” said Mark Pellegrino, chief information officer of Insmed. “The potential to extend this kind of technology to areas like drafting a clinical study report, which is incredibly labor-intensive, has profound implications for improving the efficiency and accuracy of how our industry delivers data. From the day we began to explore possibilities, Google Cloud has been in lockstep with Insmed’s ambition to transform the life sciences ecosystem.”
SOURCE: PRNewswire
